Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - REGENERX BIOPHARMACEUTICALS INC | tv505266_s1a.htm |
| EX-5.1 - EXHIBIT 5.1 - REGENERX BIOPHARMACEUTICALS INC | tv505266_ex5-1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 of RegeneRx Biopharmaceuticals, Inc. of our report, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, dated March 29, 2018, on our audits of the financial statements of RegeneRx Biopharmaceuticals, Inc. as of December 31, 2017 and 2016 and for the years then ended. We also consent to the reference to our firm under the heading “Experts.”
| /s/ CohnReznick LLP | |
| Tysons, Virginia | |
| October 11, 2018 |